Physician profile
Daniel Franco
NPI 1568494151
$18,418.83
in general payments reported to CMS, 2019-2025
64 companies · $2,894 in 2025
The $2,894 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,681 · 2020: $1,668 · 2021: $2,577 · 2022: $2,909 · 2023: $2,943 · 2024: $2,747 · 2025: $2,894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,252 · Travel and Lodging: $294 · Education: $39.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,251.91 |
| Travel and Lodging | $293.50 |
| Education | $39.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,689.74 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,500.80 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $1,236.39 | 2021-2025 | |
| Pfizer INC. | $1,208.11 | 2019-2025 | |
| Novo Nordisk INC | $1,105.47 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $993.91 | 2019-2025 | Verquvo, Belsomra, Winrevair |
| Lilly USA, LLC | $892.02 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $858.23 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $813.84 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $662.69 | 2019-2025 | |
| Amgen INC. | $589.09 | 2020-2025 | Repatha, Otezla, Evenity |
| Abbott Laboratories | $554.87 | 2021-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $475.36 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $408.37 | 2019-2024 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $372.27 | 2019-2023 | Trintellix |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $293.50 | 2024 | Excelsiusgps Robotic Navigation System |
| Arbor Pharmaceuticals, INC. | $273.42 | 2019-2021 | |
| Nuvasive, INC. | $258.86 | 2022 | |
| Nestle Healthcare Nutrition INC. | $245.70 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $243.27 | 2022 | |
| Amarin Pharma, INC. | $239.76 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $199.36 | 2020-2023 | Xifaxan |
| Astellas Pharma US INC | $159.28 | 2019-2025 | Veozah |
| Biohaven Pharmaceuticals, INC. | $152.44 | 2020-2021 | |
| Exact Sciences Corporation | $151.06 | 2023-2025 | Cologuard Collection Kit |
| Eisai INC. | $140.77 | 2020-2022 | |
| Mannkind Corporation | $118.76 | 2019-2023 | Afrezza |
| E.R. Squibb & Sons, L.L.C. | $115.19 | 2019-2023 | Eliquis |
| Xeris Pharmaceuticals, INC. | $108.42 | 2021-2025 | Gvoke Hypopen |
| Ardelyx, INC. | $92.94 | 2024-2025 | Ibsrela |
| Otsuka America Pharmaceutical, INC. | $87.42 | 2023-2025 | Rexulti |
| Sanofi Pasteur INC. | $84.54 | 2019-2024 | |
| Shield Therapeutics INC | $84.00 | 2025 | |
| Mylan Specialty L.P. | $79.24 | 2023-2024 | Yupelri |
| Scilex Pharmaceuticals INC. | $61.03 | 2023 | Ztlido |
| Corcept Therapeutics | $57.38 | 2024-2025 | Korlym |
| Medtronic, INC. | $53.47 | 2021-2023 | Mazor X System |
| Sunovion Pharmaceuticals INC. | $50.81 | 2019-2021 | |
| Almatica Pharma LLC | $45.83 | 2021-2022 | |
| Lucid Diagnostics INC. | $45.46 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $45.35 | 2024-2025 | Zoryve |
| Nevro Corp. | $43.11 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $39.98 | 2023 | Inpefa |
| Chiesi USA, INC. | $39.00 | 2025 | Filsuvez |
| Abiomed | $36.63 | 2025 | |
| Lundbeck LLC | $34.51 | 2023 | Rexulti |
| Hologic Sales and Service, LLC | $32.60 | 2021-2024 | Thinprep 2000 Processor, Aptima |
| Genzyme Corporation | $32.16 | 2025 | |
| Allergan, INC. | $29.80 | 2019-2020 | |
| Averitas Pharma INC. | $28.29 | 2025 | Qutenza |
| Radius Health, INC. | $25.45 | 2019 | |
| Dermira, INC. | $23.18 | 2020 | |
| Bausch Health US, LLC | $22.96 | 2025 | Wellbutrin, Aplenzin |
| Actelion Pharmaceuticals US, INC. | $20.84 | 2024 | Opsumit |
| Alnylam Pharmaceuticals INC. | $19.00 | 2022 | |
| Ironwood Pharmaceuticals, INC | $18.43 | 2020 | |
| Metacel Pharmaceuticals LLC | $17.82 | 2023 | Ozobax |
| Dexcom, INC. | $17.66 | 2024 | Dexcom G6 Transmitter |
| Redhill Biopharma INC. | $17.31 | 2022 | |
| Aimmune Therapeutics, INC. | $17.14 | 2024 | |
| Smith+Nephew, INC. | $13.88 | 2019 | |
| Cequr Corporation | $13.70 | 2024 | Cequr Simplicity |
| Exeltis, USA INC. | $13.49 | 2023 | Slynd |
| Azurity Pharmaceuticals, INC. | $13.47 | 2023 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Franco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.